ADIPOQ and metabolic syndrome: Adiponectin and AMPK are reduced in MetS, with concomitant metainflammation collectively increases ceramide biosynthesis and increases adipose concentrations of dihydroceramide (DHC), an intermediate of ceramide synthesis [322–324].